文献速递疝与腹壁外科围术期管理与 ERAS

坦索罗辛预防腹腔镜腹股沟疝修补术后尿潴留的随机双盲安慰剂对照研究

The use of tamsulosin to prevent postoperative urinary retention in laparoscopic inguinal hernia repair: a randomized double-blind placebo-controlled study.
PubMed 文献 · Surg Endosc · 2020-10-06

本研究为随机双盲安慰剂对照试验,纳入169例择期行完全腹膜外腹腔镜腹股沟疝修补术的男性患者,术前2小时给予坦索罗辛或安慰剂,术后24小时内评估尿潴留。结果显示总体尿潴留发生率为9%,坦索罗辛组(7.9%)与安慰剂组(9.9%)无显著差异(p=0.433)。坦索罗辛较安慰剂缩短出院时间4至68分钟。

要点

  • 择期TEP腹腔镜腹股沟疝修补术前给予坦索罗辛未显著降低术后尿潴留风险。
  • 总体术后尿潴留发生率为9%,坦索罗辛组7.9%对比安慰剂组9.9%,差异无统计学意义。
  • 坦索罗辛可能缩短出院时间4至68分钟,但需进一步验证。

核心结论

  • 术前给予坦索罗辛可能不能降低择期TEP腹腔镜腹股沟疝修补术后尿潴留的风险。

研究设计与样本

  • 随机双盲安慰剂对照试验,2017至2019年纳入169例择期行TEP腹腔镜腹股沟疝修补术的男性患者。

主要发现

  • 总体术后尿潴留发生率为9%,坦索罗辛组为7.9%,安慰剂组为9.9%,组间比较p=0.433。
  • 单因素分析显示良性前列腺增生(BPH)病史与术后尿潴留趋势相关(p=0.058)。
  • 既往报道的危险因素如高龄、总静脉输液量、手术时长和阿片类药物使用未与术后尿潴留增加相关。
  • 坦索罗辛较安慰剂缩短出院时间4至68分钟。

临床怎么用

  • 对于择期TEP腹腔镜腹股沟疝修补术的男性患者,术前坦索罗辛可能不作为常规预防术后尿潴留的措施。

局限性

  • 样本量可能不足以检测出统计学显著差异,需要更大样本量的进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The rate of postoperative urinary retention (POUR) in laparoscopic inguinal hernia repairs is 1-22%. POUR may cause patient anxiety, discomfort, and increased hospital costs. Currently there is no standard prophylaxis for POUR. Preoperative administration of tamsulosin has been shown to decrease POUR rates in urologic studies. This study aims to evaluate the efficacy of tamsulosin on the incidence of POUR in patients undergoing totally extraperitoneal (TEP) LIHR. METHODS: A randomized, double-blinded, placebo-controlled trial was initiated and accrued patients from 2017 to 2019. A total of 169 males undergoing elective TEP LIHR were included. Patients were administered tamsulosin 2 h before surgery and followed for up to 24 h postoperatively for episodes of POUR. Analysis was performed to quantify the association between patient, surgical, and perioperative factors with POUR. RESULTS: The overall rate of POUR was 9%. There was no difference in the rate of POUR between the placebo (9.9%) and tamsulosin groups (7.9%) (p = 0.433). Univariate analysis showed a trend toward POUR in patients with history of benign prostatic hypertrophy (BPH) (p = 0.058). Previously reported risk factors of older age, total IVF, length of procedure and opioid use were not associated with increased rates of POUR. Tamsulosin reduced the time to discharge by 4 to 68 min when compared to placebo. CONCLUSIONS: This study suggests that preoperative administration of tamsulosin may not reduce the risk of POUR in males undergoing elective TEP LIHR. Further study with a larger sample size may be needed to show a statistically significant difference.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Caparelli ML, Shikhman A, Runyan B, et al. The use of tamsulosin to prevent postoperative urinary retention in laparoscopic inguinal hernia repair: a randomized double-blind placebo-controlled study. Surg Endosc. 2020. PMID: 33025252. doi:10.1007/s00464-020-08050-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。